Sean Maduck, See Remarks at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $83.73 ($3.4M) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($3.4M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.73 | 959 | $80K | 2.4% |
| 2 | $83.73 | 959 | $80K | 2.4% |
| 3 | $85.06 | 16,394 | $1.4M | 41.0% |
| 4 | $85.06 | 16,394 | $1.4M | 41.0% |
| 5 | $85.58 | 2,647 | $227K | 6.7% |
| 6 | $85.58 | 2,647 |
| $227K |
| 6.7% |
| Total | $85.07 avg | 40,000 | $3.4M | 100% |
| Filing → |
| CORT | SELL | 2026-08-18 | $419K | — | Filing → |
| CORT | SELL | 2026-08-12 | $118K | — | Filing → |
| CORT | SELL | 2026-08-05 | $2.3M | — | Filing → |